178 related articles for article (PubMed ID: 17383162)
1. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.
Weikop P; Yoshitake T; Kehr J
Eur Neuropsychopharmacol; 2007 Oct; 17(10):658-71. PubMed ID: 17383162
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
[TBL] [Abstract][Full Text] [Related]
4. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
Millan MJ; Gobert A; Girardon S; Dekeyne A
Eur J Pharmacol; 1999 Jan; 364(2-3):147-50. PubMed ID: 9932717
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
Pozzi L; Invernizzi R; Garavaglia C; Samanin R
J Neurochem; 1999 Sep; 73(3):1051-7. PubMed ID: 10461894
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
7. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
Montezinho LP; Miller S; Plath N; Jensen NH; Karlsson JJ; Witten L; Mørk A
Psychopharmacology (Berl); 2010 Oct; 212(2):131-43. PubMed ID: 20676614
[TBL] [Abstract][Full Text] [Related]
8. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
Umehara M; Ago Y; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Eur J Pharmacol; 2013 Feb; 702(1-3):250-7. PubMed ID: 23376565
[TBL] [Abstract][Full Text] [Related]
9. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
[TBL] [Abstract][Full Text] [Related]
10. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522408
[TBL] [Abstract][Full Text] [Related]
12. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
Muraki I; Inoue T; Hashimoto S; Izumi T; Koyama T
Psychiatry Clin Neurosci; 2008 Oct; 62(5):568-74. PubMed ID: 18950377
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
[TBL] [Abstract][Full Text] [Related]
14. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
[TBL] [Abstract][Full Text] [Related]
15. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
[TBL] [Abstract][Full Text] [Related]
16. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
Kleijn J; Cremers TI; Hofland CM; Westerink BH
Neurosci Res; 2011 Jul; 70(3):334-7. PubMed ID: 21420449
[TBL] [Abstract][Full Text] [Related]
17. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kakuta A; Izumi T; Koyama T
Eur J Pharmacol; 2010 Nov; 647(1-3):90-6. PubMed ID: 20816814
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation.
Valentini V; Cacciapaglia F; Frau R; Di Chiara G
J Neurochem; 2005 Apr; 93(2):371-82. PubMed ID: 15816860
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
Navailles S; Bioulac B; Gross C; De Deurwaerdère P
Neurobiol Dis; 2010 Apr; 38(1):136-43. PubMed ID: 20096781
[TBL] [Abstract][Full Text] [Related]
20. Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity.
Golembiowska K; Kowalska M; Bymaster FP
Synapse; 2012 May; 66(5):435-44. PubMed ID: 22213370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
